DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities
Background Prolonged use of anticholinergic and sedative medicines is correlated with worsening cognition and physical function decline. Deprescribing is a proposed intervention that can help to minimise polypharmacy whilst potentially improving several health outcomes in older people. Objective This study aimed to examine the feasibility of implementing a deprescribing intervention that utilises a patient-centred pharmacist-led intervention model; in order to address major deprescribing challenges such as general practitioner time constraints and lack of accessible deprescribing guidelines and processes. Setting Three residential care facilities. Methods The intervention involved a New Zealand registered pharmacist utilising peer-reviewed deprescribing guidelines to recommend targeted deprescribing of anticholinergic and sedative medicines to GPs. Main outcome measure The change in the participants’ Drug Burden Index (DBI) total and DBI ‘as required’ (PRN) was assessed 3 and 6 months after implementing the deprescribing intervention. Results Seventy percent of potential participants were recruited for the study (n = 46), and 72% of deprescribing recommendations suggested by the pharmacist were implemented by General Pratitioners (p = 0.01; Fisher’s exact test). Ninety-six percent of the residents agreed to the deprescribing recommendations, emphasising the importance of patient centred approach. Deprescribing resulted in a significant reduction in participants’ DBI scores by 0.34, number of falls and adverse drug reactions, 6 months post deprescribing. Moreover, participants reported lower depression scores and scored lower frailty scores 6 months after deprescribing. However, cognition did not improve; nor did participants’ reported quality of life. Conclusion This patient-centred deprescribing approach, demonstrated a high uptake of deprescribing recommendations and success rate. After 6 months, significant benefits were noted across a range of important health measures including mood, frailty, falls and reduced adverse reactions. This further supports deprescribing as a possible imperative to improve health outcomes in older adults.
KeywordsAnticholinergic Deprescribing Drug burden index Elderly Feasibility study New Zealand Sedatives
The authors appreciate the co-operation of the residential care provider who agreed to take part in the study.
This study was funded by the Lotteries Health Research (LHR). No other funding was received for this study.
Conflicts of interest
The author(s) declare no competing interests and are responsible for this report’s content.
- 1.Jansen J, Naganathan V, Carter SM, McLachlan AJ, Nickel B, Irwig L, et al. Too much medicine in older people? Deprescribing through shared decision making. BMJ (Clin Res Ed). 2016;353:i2893.Google Scholar
- 9.Garfinkel D, Zur-Gil S, Ben-Israel J. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J. 2007;9(6):430–4.Google Scholar
- 21.CONSORT: Transparent, Recording, of, trails. The CONSORT flow diagram 2016. http://www.consort-statement.org/consort-statement/flow-diagram. Accessed Oct 2016.
- 24.Crotty M, Rowett D, Spurling L, Giles LC, Phillips PA. Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriatr Pharmacother. 2004;2(4):257–64.CrossRefGoogle Scholar
- 25.InterRAI Long Term Care Facilities. The InterRAI organisation: Mission and Vision 2016. http://www.interrai.org/index.php?id=2. Accessed April 2017.
- 28.Edmonton Frailty Scale. https://www.nscphealth.co.uk/edmontonscale-pdf. Accessed May 2017.
- 32.Team R Core. R: a language and environment for statistical computing 2016. http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.470.5851&rep=rep1&type=pdf. Accessed Sep 2017.